Health Products

Simplexa Flu A/B & RSV Direct

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - Microbiology
Product: Simplexa Flu A/B & RSV Direct
Issue: Medical devices - Performance
What to do: Discontinue using remaining inventory, share recall notice with users, complete/return response form.
Audience: Healthcare
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberAffected productsModel or catalog number
15279NSimplexa Flu A/B & RSV DirectMOL2655

Issue

Customer complaints were received for disc leaks while running Simplexa Covid-19 Direct kit with assay definition version 2 (high spin & temp). Leakage was confirmed by retain testing on 1/6/22 with discs run on Covid-19 Direct assay definition version 2. No disc leakage occurred with version 3 (reduced spin & temp). Simplexa Flu A/B & RSV (mol2655) and Simplexa Covid-19 & Flu A/A Direct (mol4250) have similar assay definitions and are also at risk for leakage.

Recall start date: February 01, 2023

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime